Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lorch

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
The Oncologist|April 21, 2020
The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland CancersGlenn J Hanna, Ji Eun Bae, Jochen H Lorch, et al.
Oral Oncology|November 15, 2020
Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19Glenn J Hanna, Eleni M Rettig, Jong C Park, et al.
British Journal of Cancer|July 6, 2016
Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancerVishwajith Sridharan, Danielle N Margalit, Stephanie A Lynch, et al.
Oral Oncology|October 1, 2016
Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrencesDanielle N Margalit, Bhupendra Rawal, Paul J Catalano, et al.
Head & Neck|January 9, 2019
IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparingAnna W LaVigne, Danielle N Margalit, Bhupendra Rawal, et al.
Journal for Immunotherapy of Cancer|January 20, 2018
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trialHoward L Kaufman, Jeffery S Russell, Omid Hamid, et al.
Annals of Surgical Oncology|June 26, 2020
Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association GuidelinesLindsay E Kuo, Trevor E Angell, T K Pandian, et al.
The Oncologist|August 12, 2016
Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled TrialWeidong Lu, Peter M Wayne, Roger B Davis, et al.
Oral Oncology|June 6, 2021
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinomaGlenn J Hanna, Anne ONeill, Jennifer M Cutler, et al.
Oral Oncology|March 30, 2017
Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatmentYuehan Zhang, Tim Waterboer, Robert I Haddad, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
The Oncologist|April 21, 2020
The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland CancersGlenn J Hanna, Ji Eun Bae, Jochen H Lorch, et al.
Oral Oncology|November 15, 2020
Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19Glenn J Hanna, Eleni M Rettig, Jong C Park, et al.
British Journal of Cancer|July 6, 2016
Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancerVishwajith Sridharan, Danielle N Margalit, Stephanie A Lynch, et al.
Oral Oncology|October 1, 2016
Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrencesDanielle N Margalit, Bhupendra Rawal, Paul J Catalano, et al.
Head & Neck|January 9, 2019
IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparingAnna W LaVigne, Danielle N Margalit, Bhupendra Rawal, et al.
Journal for Immunotherapy of Cancer|January 20, 2018
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trialHoward L Kaufman, Jeffery S Russell, Omid Hamid, et al.
Annals of Surgical Oncology|June 26, 2020
Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association GuidelinesLindsay E Kuo, Trevor E Angell, T K Pandian, et al.
The Oncologist|August 12, 2016
Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled TrialWeidong Lu, Peter M Wayne, Roger B Davis, et al.
Oral Oncology|June 6, 2021
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinomaGlenn J Hanna, Anne ONeill, Jennifer M Cutler, et al.
Oral Oncology|March 30, 2017
Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatmentYuehan Zhang, Tim Waterboer, Robert I Haddad, et al.
Pageof 9